Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Plasma cell 3Lymphoid 3Breast 3Other hematologic neoplasm 2Other 1

Conditions

Leukemia, Myeloid, Acute 874Precursor Cell Lymphoblastic Leukemia-Lymphoma 499Hematologic Neoplasms 462Leukemia, Lymphocytic, Chronic, B-Cell 388Leukemia 328Myelodysplastic Syndromes 324Lymphoma 203Lymphoma, Non-Hodgkin 191Multiple Myeloma 145Leukemia, Myelogenous, Chronic, BCR-ABL Positive 139Recurrence 136Neoplasms 133Leukemia, Myelomonocytic, Chronic 110Burkitt Lymphoma 92Lymphoma, Mantle-Cell 91Lymphoma, Follicular 91Lymphoma, Large B-Cell, Diffuse 88Myeloproliferative Disorders 84Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 81Leukemia, Biphenotypic, Acute 79Lymphoma, B-Cell, Marginal Zone 75Hodgkin Disease 72Lymphoma, B-Cell 64Waldenstrom Macroglobulinemia 54Primary Myelofibrosis 53Leukemia, B-Cell 50Anemia, Refractory, with Excess of Blasts 45Leukemia, Myeloid, Chronic-Phase 40Hematologic Diseases 37Lymphoma, T-Cell 32

Interventions

Standard of Care 1Practice Guidelines as Topic 1Mesenchymal Stem Cell Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Cardiomyopathies × Other hematologic neoplasm × 1 year × Clear all
NCT02962661 2026-01-07

Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines

M.D. Anderson Cancer Center

Phase 1 Recruiting
72 enrolled
Other hematologic neoplasm

Heart Failure, Cardiomyopathies, Hematologic Neoplasms

NCT06350994 2025-09-02

Cardio CAR-T

Assistance Publique - Hôpitaux de Paris

Recruiting
60 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Multiple Myeloma, Cardiomyopathies, Lymphoma, B-Cell, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡